Skip to main content
OpenTrials

Clinical trial condition

Medulloblastoma

Explore clinical trials studying Medulloblastoma. Study availability and eligibility vary by location and protocol.

87 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Medulloblastoma trial results

Completed

An East Asian Study of LDE225

NCT01208831

Conditions
Advanced Solid Tumor Cancers, Basal Cell Carcinoma, Carcinoma, +12 more
Locations
  • Novartis Investigative Site Hong Kong
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Kobe, Hyōgo, Japan
  • Novartis Investigative Site Taipei, Taiwan
View Trial Details
Completed

Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors

NCT02502708

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +24 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Arnold Palmer Hospital for Children Orlando, Florida, United States
  • Children's Heathcare of Atlanta Atlanta, Georgia, United States
  • Augusta University Augusta, Georgia, United States
View Trial Details
Completed

A Phase II Study of Oral LDE225 in Patients With Hedge-Hog (Hh)-Pathway Activated Relapsed Medulloblastoma (MB)

NCT01708174

Conditions
Disease Attributes, Glioma, Medulloblastoma, +11 more
Locations
  • Ann & Robert H. Lurie Children Dept of Oncology Chicago, Illinois, United States
  • Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. Dept Onc Baltimore, Maryland, United States
  • Dana Farber Cancer Institute SC-7 Boston, Massachusetts, United States
  • Columbia University Medical Center- New York Presbyterian Dept of Oncology New York, United States
View all 41 locations
View Trial Details
Completed

p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors

NCT01975116

Conditions
Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Astrocytoma, +28 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Lurie Children's Hospital-Chicago Chicago, Illinois, United States
View Trial Details
Completed

A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB

NCT01125800

Conditions
Astrocytoma, Disease Attributes, Glioma, +21 more
Locations
  • Children's Healthcare of Atlanta Childern Hosp - ATL Atlanta, Georgia, United States
  • Sidney Kimmel Comprehensive Cancer Center/Johns Hopkins Med. John Hopkins Baltimore, Maryland, United States
  • Dana Farber Cancer Institute DFCI (3) Boston, Massachusetts, United States
  • Seattle Children's Hospital CPKC412A2114 Seattle, Washington, United States
View all 14 locations
View Trial Details
Completed

Combination of Irinotecan and Temozolomide in Children With Brain Tumors.

NCT00404495

Conditions
Glioma, Medulloblastoma, Neoplasms, +7 more
Locations
  • Pfizer Investigational Site Westmead, New South Wales, Australia
  • Pfizer Investigational Site Herston, Queensland, Australia
  • Pfizer Investigational Site Parkville, Victoria, Australia
  • Pfizer Investigational Site Ghent, Belgium
View all 29 locations
View Trial Details

Related conditions